Human Vaccines & Immunotherapeutics · 2014 · 37 citations · 34 references
Veterinary MedicineBiotechnologyImmunologyProtein BiochemistryVaccine ImmunologyVaccinologyConjugate VaccinesSubunit VaccinesToxoid VaccinesVaccine FormulationVaccine SafetyVaccine StabilityDiphtheria Toxoid VaccinePneumococcal Conjugate VaccinationPneumococcal Conjugate VaccinesProtein Conformation AnalysisProtein Conformation ChangeThermal StabilityThermal Stability Of VaccinesVaccine Characterization
Physico-chemical analysis of pneumococcal polysaccharide (PS)-protein conjugate vaccine components used for two commercially licensed vaccines was performed to compare the serotype- and carrier protein-specific stabilities of these vaccines. Nineteen different monovalent pneumococcal conjugates from commercial vaccines utilizing CRM197, diphtheria toxoid (DT), Protein D (PD) or tetanus toxoid (TT) as carrier proteins were incubated at temperatures up to 56°C for up to eight weeks or were subjected to freeze-thawing (F/T). Structural stability was evaluated by monitoring their size, integrity and carrier protein conformation. The molecular size of the vaccine components was well maintained for Protein D, TT and DT conjugates at -20°C, 4°C and F/T, and for CRM197 conjugates at 4°C and F/T. It was observed that four of the eight serotypes of Protein D conjugates tended to form high molecular weight complexes at 37°C or above. The other conjugated carrier proteins also appeared to form oligomers or 'aggregates' at elevated temperatures, but rarely when frozen and thawed. There was evidence of degradation in some of the conjugates as evidenced by the formation of lower molecular weight materials which correlated with measured free saccharide. In conclusion, pneumococcal-Protein D/TT/DT and most CRM197 bulk conjugate vaccines were stable when stored at 2-8°C, the recommended temperature. In common between the conjugates produced by the two manufacturers, serotypes 1, 5, and 19F were relatively less stable and 6B was the most stable, with types 7F and 23F also showing good stability.
34
William P. Hausdorff, John Bryant, Peter R. Paradiso et al. · Clinical Infectious Diseases · 2000 · 872 citations
Veterinary Medicine, Infectious Diseases, Preventive Medicine +15
Roman Prymula, Pascal Peeters, Viktor Chrobok et al. · The Lancet · 2006 · 640 citations
Roman Prymula, Pascal Peeters, Viktor Chrobok et al. · Clinical Otolaryngology · 2006 · 523 citations
Timo Vesikari, Jacek Wysocki, Bertrand Chevallier et al. · The Pediatric Infectious Disease Journal · 2009 · 271 citations